News: $AAC Addiction Labs of America Developing Pharmacogenetics Test for Cannabis and CBD
BRENTWOOD, Tenn. , May 23, 2019 /PRNewswire/ -- Addiction Labs of America , the laboratory division of American Addiction Centers (NYSE: AAC), is in the early stages of developing a pharmacogenetics test for cannabis and other cannabis products, such as cannabidiol (CBD)...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.